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1. Introduction
  Currently there are over 346 million diabetics worldwide 
and this number is likely to increase in a 50% or more by 
the year 2020 due to increases in a sedentary lifestyle, 
consumption of energy rich diets, and obesity[1]. Providing 
modern medical healthcare across the world is still a distant 
goal due to economic constraints. Thus, it is necessary 
that we continue to look for new, and if possible, more 
efficacious drugs and phytotherapy may be an ideal target[2].
  Although natural supplements are widely used around the 
world to treat diabetes, few of them have been scientifically 
validated[3]. Validating the effectiveness of herbs and other 
medicinal plants for treatment of diabetes in mammalian 
animal models is a very low priority and is costly, 
resulting in a gap in the drug development process. Fish 
are a vertebrate model organism that can bridge this gap. 
Recently, zebrafish have been proposed as a model for the 
regulation of glucose levels, by exposing adult and larval 
zebrafish to known anti-hyperglycemic compounds[4].
  Ocimum tenuiflorum (O. tenuiflorum), a member of the 
family Lamiaceae (Labiatae), is a tropical herb, up to 18 
inches tall, that grows into a low bush. The plant grows 
wild in Cuba but is also widely cultivated in gardens. 
The aqueous extract of O. tenuiflorum is used as an anti-
hyperglycemic in Cuba[5]. In this study, we investigated the 
effect of O. tenuiflorum aqueous extract on level of blood 
glucose in tilapia [Oreochromis niloticus (O. niloticus)], as a 
new fish model for diabetes.
 
Objective: To evaluate, in hyperglycemic tilapia [Oreochromis niloticus (O. niloticus)], the effect 
of this aqueous extract on blood glucose levels. Methods: The hyperglycemia in O. niloticus 
was induced by adding glucose to fish pond water. An aqueous extract of Ocimum tenuiflorum 
(O. tenuiflorum) was prepared by boiling fresh leaves and the doses of 0, 40, 80, 200 and 400 
mg per liter of pond water were tested. Results: The blood sugar concentration for tilapia with 
hyperglycemic induced was an average of 50% higher than the control group. The blood glucose 
levels in tilapia after the induction of hyperglycemia were higher than the control group for
90 min after the treatment. The treatment with the aqueous extract of O. tenuiflorum dropped 
the serum glucose level of hyperglycemic tilapia until it was similar to that of the control group 
and was dose dependent. Conclusions: The results indicated that O. tenuiflorum was endowed 
with anti-hyperglycemic activity. To our knowledge, this is the first report on the use of fish as a 
diabetes model to test natural extracts from plants.
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2. Materials and methods
2.1. Fish
  Male juvenile tilapia (O. niloticus) weighting (46.6 ± 4.8) g 
was supplied by Fisheries Department of Camagüey, Cuba. 
The animals were maintained in the laboratory at (27 ± 2) 曟 
in aerated water. Tilapia was kept throughout in a 14 h light: 
10 h dark photoperiod and fed ad libitum with fish pellets 
containing 30% proteins (Malta-Cleyton, Mexico).
2.2. Inducing hyperglycemia in tilapia
  Five groups were made with 7 animals in each. Glucose 
was added to the fish pond at 0, 25, 50, 75 and 100 g/L and 
fish were kept in this water for 30 min. Then the fish were 
passed to clean freshwater and blood samples were taken. 
2.3. Hyperglycemic time course in tilapia
  Two groups were made with 45 animals each. One group 
was used as control and to the other group hyperglycemia 
was induced by adding glucose to the fish pond at 50 g/L.
Fish were pretreated for 30 min and blood samples were 
taken 0, 15, 30, 60, 90 and 120 min after the fish were passed 
to clean freshwater. Blood samples were also taken before 
the induction of hyperglycemia.
2.4. Plant and preparation of extract
  O. tenuiflorum was collected from the organoponic “La 
Victoria”, carretera central, Camagüey, Cuba; and was 
identified by Professor Jorge E. Gutiérrez of the Botany 
Department, University of Havana, Cuba. Voucher sample 
was deposited in the herbarium collection of the National 
Botanical Garden, Havana, Cuba (voucher specimen no. 
HAJB 87 101). An aqueous extract was prepared by boiling 
120 g of the fresh leaves in approximately 1 L for 15 min. The 
extract was filtered, adjusted to a volume of one liter and 
used immediately. Part of the extract was placed in the oven 
(40 曟) to detect the dry weight. 
2.5. Evaluation of the O. tenuiflorum extract 
  Four groups were made with 7 animals each. One group 
without treatment was used as control and hyperglycemia 
was induced in the other three groups. After 30 min of 
incubation with glucose at 50 g/L the animals were passed 
to clean freshwater. Animals from the second group were 
injected with human insulin (Roche). The third group was 
incubated with O. tenuiflorum extract at 200 mg/L. The last 
group was incubated in freshwater without further treatment. 
After 1 h blood samples were taken from all animals.
2.6. O. tenuiflorum extract doses
  Six groups were made with 7 animals each. One group 
without treatment was used as control and hyperglycemia 
was induced in the other fifth groups. After 30 min of 
incubation with glucose at 50 g/L the animals were passed to 
clean freshwater. The groups were treated with the doses 0, 
40, 80, 200 and 400 mg/L of the O. tenuiflorum leaf extract, 
respectively. The last group was incubated in freshwater 
without further treatment. After 1 h blood samples were 
taken from all animals.
2.7. Blood samples and serum glucose measurements
  About 150 毺L of blood was removed from the caudal vein 
of each fish. The blood samples were incubated at 37 曟 for 
10 min, and serum were obtained by centrifuging at 2 000 g 
for 5 min. Glucose levels were estimated by commercially 
available glucose kits based on the glucose oxidase method 
(Quimefa®, Cuba).
2.8. Data analysis
  All data were tested for normality and assessed by one-way 
analysis of variance (ANOVA). Differences were detected by 
Student-Newman-Keuls Post-Hoc Test.
  
3. Results
  Adding glucose to fish pond water induced hyperglycemia 
in tilapia (O. niloticus). At 25 g/L of glucose in pond 
water increased the blood sugar concentration of tilapia 
by 27% compared to the control group. The blood sugar 
concentration in tilapia showed saturation when more than 
50 g/L of glucose was added to the pond water. An average 
increase of 50% in blood sugar concentration compared to 
the control group was observed when 50 to 100 g/L glucose 
was added to the pond water (Figure 1).
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Figure 1. Induction of hyperglycemia in tilapia (O. niloticus) after 
glucose addition to the fish pond water. 
Glucose was added to the fish pond at 0, 25, 50, 75 and 100 g/L, 
respectively. Thirty min later, animals were passed to clean freshwater 
and blood samples were taken. Different letters indicate statistical 
differences (P<0.05). T Bars indicate the SEM at each point (n=7).
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  Even 90 min after the induction of hyperglycemia in
O. niloticus, the serum glucose was higher than the control 
group. The highest glucose blood value (6.76 ± 0.49) mmol/L
was obtained 15 min after the beginning of the induction 
period. The blood glucose level remained high for 60 min 
after the fish incubation with glucose. The serum glucose 
decreased to (4.48 ± 0.24) mmol/L, but was still significantly 
higher than the control group (3.18 ± 0.29) mmol/L. Two hours 
after induction of hyperglycemia, the serum glucose dropped 
to values similar to those of the control group (Figure 2).
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Figure 2. Time course of serum glucose in tilapia (O. niloticus) after 
induction of hyperglycemia. 
Glucose was added to the fish pond at 50 g/L for the experimental 
groups; 30 min later the treated animals were passed to clean 
freshwater. Blood samples were taken before the glucose addition 
and at 0, 15, 30, 60 and 90 min after the induction of hyperglycemia. 
The control group didn’t receive any treatment. Arrows indicate the 
beginning (I) and the end (II) of the induction period. Different letters 
indicate statistical differences (P<0.05). T Bars indicate the SEM at 
each point (n=5).
  Administrating aqueous extract of O. tenuiflorum leaves 
showed a significant reduction of serum glucose levels 
in glucose-treated tilapia. The serum glucose values of 
tilapia treated with the plant extract (3.26 ± 0.62) mmol/L
were similar to the control group (3.54 ± 0.55) mmol/L. The 
glucose serum in animals injected with human insulin 
also decreased to values (3.11 ± 0.58) mmol/L similar to the 
control group. The hyperglycemic group that did not receive 
further treatment had serum blood levels (5.39 ± 1.18) mmol/L
significantly higher those of the control group. 
  The results showed that the leaf extracts of O. tenuiflorum 
possess significant blood sugar lowering potential in 
hyperglycemic tilapia model and were dose dependent. 
The serum glucose values of tilapia treated with 200 mg/L
(3.25 ± 0.57) mmol/L and 400 mg/L (3.33 ± 0.55) mmol/L of 
plant extract were similar to the control group (3.09 ± 0.82) 
mmol/L. However, the hyperglycemic group that received
80 mg/L treatment had serum blood levels (4.51 ± 0.34) mmol/L
significantly higher those of the control group, but lower 
than the hyperglycemic group that did not receive further 
treatment (6.33 ± 0.71) mmol/L. Moreover, the dose of 40 mg/L
of O. tenuiflorum extract did not decrease the serum blood 
levels (6.26 ± 0.68) mmol/L in induced hyperglycemic tilapia.
 
4. Discussion
  Diabetes mellitus is a serious chronic disease. Although 
oral anti-hyperglycemic agents and insulin are often 
successful in diabetes treatment[6], they have prominent 
side effects and fail to significantly alter the course of 
diabetic complications[7, 8]. Medicinal herbs are expected to 
have a similar degree of efficacy without the troublesome 
side effects associated with conventional drug treatment[9]. 
Ideally, preclinical in vivo experiments should be carried out 
before using herbal treatments[3, 10]. 
  Various animal models have been developed to examine 
diabetes. Most models use primates, small mammals, mice or 
rats, in which diabetes has been chemically induced through 
the injection of streptozotocin or alloxan[11]. The chemicals 
used to induce insulin dependent diabetes have side effects, 
including kidney, lung and liver tumors (streptozotocin) or 
liver and kidney necrosis (alloxan), which illustrates the lack 
of specificity of these drugs and may affect blood glucose 
levels[12].
  In the present paper, hyperglycemia was induced in 
tilapia by adding glucose to the fish pond water. This is in 
agreement with the induction of hyperglycemia in adult 
zebrafish that was proposed as a model to study diabetic 
retinopathy[13]. These authors found that zebrafish incubated 
in glucose solutions above 50 g/L suffered impairment or 
death within 4 h. To induce hyperglycemia in tilapia we 
incubated the fish for only 30 min and no fish death was 
observed. 
  Larval zebrafish may be an appropriate model 
for the examination of glucose metabolism, using 
phosphoenolpyruvate carboxykinase as an indicator of 
blood glucose levels[4]. Because it is larger, tilapia, has an 
advantage over zebrafish for studying glucose levels and 
organs. The data presented in this paper indicate that tilapia 
is a suitable model for testing medicinal herbs that have 
anti-hyperglycemic activity. The decision of which model 
of diabetes to use for any particular protocol is mainly 
influenced by local resources[3].
  The decrease of serum glucose observed after the 
administration human insulin in tilapia (O. niloticus), is 
in agreement with the homology between fish and human 
insulins. Fish insulins have been demonstrated to be 
functional in mice and humans[14]. However, transgenic 
tilapia expressing “tilapia humanized insulin” have been 
examined as a way to avoid anti-insulin antibody production 
in human xenotransplantation[15]. 
  In the present study, an aqueous leaf extract of O. tenuiflorum 
produced a significant fall in blood glucose levels of 
hyperglycemic tilapia. Different extracts of plants from the 
family Lamiaceae (Labiatae) have also been shown to have 
anti-hyperglycemia activity[16]. Intraperitoneal injection in 
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normal and diabetic rats of methanolic extract of Ocimum 
gratissimum leaves significantly reduced glucose plasma 
level by 56% and 68%, respectively[17]. Ethanolic extract of 
Ocimum sanctum leaves showed hypoglycemic effects (26%) 
in normal albino rabbits[2]. Administration of aqueous extract 
of Ocimum canum decreased fasting blood glucose levels in 
diabetic and non-diabetic C57BL/KsJ mice[18,19]. 
  In this paper, it was observed that the leaf extracts of
O. tenuiflorum possess significant dose-dependent blood 
sugar lowering activity in hyperglycemic tilapia. The fact 
that neither toxicity nor lethality was observed at any doses 
of the O. tenuiflorum extract explains the wide safety margin 
of the extracts within the doses range. This is in agreement 
with the findings ethanol and aqueous extracts of the leaves 
of Ocimum suave and Ocimum lamiifolium that showed 
antipyretic activities in mice[20].
  This is the first report that demonstrates the serum-
glucose lowering activity of the aqueous leaf extract of 
O. tenuiflorum in hyperglycemic fish. Further studies are 
necessary to reveal the mechanism of action of this extract 
in decreasing blood glucose level. The new tilapia model we 
are proposing may help to accelerate these studies and test 
plant extracts.
Conflict of interest statement
  We declare that we have no conflict of interest.
Acknowledgements
  We thank Dr. John van der Meer (Pan-American 
Marine Biotechnology Association) for advice on English 
improvement for the manuscript.  
References
[1]   WHO. Fact sheet N°312. [Online]. Available from: http://www.
who.int/mediacentre/factsheets/fs312/ [Accessed on August 2011].
[2]   Vats V, Yadav SP, Grover JK. Ethanolic extract of Ocimum 
sanctum leaves partially attenuates streptozotocin-induced 
alterations in glycogen content and carbohydrate metabolism in 
rats. J Ethnopharmacol 2004; 90: 155-160.
[3]   Fröde FTS, Medeiros YS. Animal models to test drugs with 
potential anti-diabetic activity. J Ethnopharmacol 2008; 15: 173-
183.
[4]   Elo B, Villano CM, Govorko D, White LA. Larval zebrafish as a 
model for glucose metabolism: expression of phosphoenolpyruvate 
carboxykinase as a marker for exposure to anti-diabetic 
compounds. J Mol Endocrinol 2007; 38: 433-440.
[5]   Carmona R, López OD, Gonzáles ML, Fernández EG, Barzaga 
P. Optimizing a process to obtain Ocimum sanctum L. (albaca 
morada) aqueous extract. Rev Cubana Plant Med 2009; 3: 14-22.
[6]  Arokiyaraj S, Balamurugan R, Augustian P. Antihyperglycemic 
effect of Hypericum perforatum ethyl acetate extract on 
streptozotocin-induced diabetic rats. Asian Pac J Trop Biomed 
2011; 1(5): 386-390.
[7]   Setacci C, de Donato G, Setacci F, Chisci E. Diabetic patients: 
epidemiology and global impact. J Cardiovasc Surg 2009; 50(3): 
263-273.
[8]  Patel DK, Kumar R, Prasad SK, Sairam K, Hemalatha S. 
Antidiabetic and in vitro antioxidant potential of Hybanthus 
enneaspermus (Linn) F. Muell in streptozotocin-induced diabetic 
rats. Asian Pac J Trop Biomed 2011; 1(4): 316-322.
[9]   Kim SH, Hyun SH, Choung SY. Anti-diabetic effect of cinnamon 
extract on blood glucose in db/db mice. J Ethnopharmacol 2006; 
104: 119-123.
[10]  Thirumalai T, Therasa SV, Elumalai EK, David E. Hypoglycemic 
effect of Brassica juncea (seeds) on streptozotocin induced 
diabetic male albino rat. Asian Pac J Trop Biomed 2011; 1(4): 
323-325.
[11]  Suganya S, Narmadha R, Gopalakrishnan VK, Devaki K. 
Hypoglycemic effect of Costus pictus D. Don on alloxan induced 
type 2 diabetes mellitus in albino rats. Asian Pac J Dis 2012; 
2(3): 117-123.
[12]   Lenzen S. The mechanisms of alloxan- and streptozotocin-
induced diabetes. Diabetologia 2008; 51(2): 216-226.
[13]   Gleeson M, Connaughton V, Arneson LS. Induction of 
hyperglycaemia in zebrafish (Danio rerio) leads to morphological 
changes in the retina. Acta Diabetol 2007; 44: 157-163.
[14] Wright JR Jr, Pohajdak B. Cell therapy for diabetes using piscine 
islet tissue. Cell Transplant 2001; 10: 125-143.
[15] Pohajdak B, Mansour M, Hrytsenko O, Conlon JM, Dymond LC, 
Wright JR Jr. Production of transgenic Tilapia with Brockmann 
bodies secreting [desThrB30] human insulin. Transgenic Res 
2004; 13: 313-323.
[16]  Balamurugan R, Ignacimuthu S. Antidiabetic and hypolipidemic 
effect of methanol extract of Lippia nodiflora L. in streptozotocin 
induced diabetic rats. Asian Pac J Trop Biomed 2011; 1(Suppl 1): 
S30-S36.
[17] Aguiyi JC, Obi CI, Gang SS, Igweh A. Hypoglycaemic activity of 
Ocimum gratissimum in rats. Fitoterapia 2000; 71: 444-446.
[18] Nyarko AK, Asare-Anane Ofosuhene M, Addy ME. Extract 
of Ocimum canum lowers blood glucose and facilitates insulin 
release by isolated pancreatic 毬-islet cells. Phytomedicine 2002; 
9: 346-351. 
[19] Nyarko AK, Asare-Anane H, Ofosuhene M, Addy ME, Teye 
K, Addo P. Aqueous extract of Ocimum canum decreases 
levels of fasting blood glucose and free radicals and increases 
antiatherogenic lipid levels in mice. Vasc Pharmacol 2003; 39: 
273-279.
[20] Makonnen E, Debella A, Zerihun L, Abebe D, Teka F. 
Antipyretic properties of the aqueous and ethanol extracts of 
the leaves of Ocimum suave and Ocimum lamiifolium in mice. J 
Ethnopharmacol 2003; 88: 85-91.
